Dominik Horn
Overview
Explore the profile of Dominik Horn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
293
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Radermacher A, Horn D, Fehrenz M, Semmelmayer K, Ristow O, Engel M, et al.
Craniomaxillofac Trauma Reconstr
. 2024 Nov;
:19433875241272437.
PMID: 39544316
Study Design: Retrospective cohort study. Objective: A major risk factor for oral squamous cell carcinoma (OSCC) is advanced age. Ablative surgery combined with microvascular reconstruction has become routine for OSCC....
2.
Moratin J, Zittel S, Ristow O, Hoffmann J, Freier K, Horn D
J Stomatol Oral Maxillofac Surg
. 2024 Oct;
126(4):102121.
PMID: 39424061
Background: Oral squamous cell carcinoma (OSCC) ranks on position 14 in global cancer analysis and makes up to 38 % of all head and neck squamous cell carcinomas. While surgery...
3.
Steen S, Horn D, Flechtenmacher C, Hoffmann J, Freier K, Ristow O, et al.
Head Neck
. 2024 Aug;
47(2):437-451.
PMID: 39180200
Background: Lately SOX2 and SOX9, transcription factors associated with stemness-like phenotypes of cancer cells, have been linked to tumor growth, metastasis, and resistance to therapy. Methods: This study aimed on...
4.
Moratin J, Horn D, Oehme M, Semmelmayer K, Flechtenmacher C, Ristow O, et al.
Clin Oral Investig
. 2024 May;
28(6):327.
PMID: 38764079
Objectives: Surgical resection is a key component of the treatment of head and neck cancer and the achievement of free surgical margins are essential for the patients' outcome in terms...
5.
Warmerdam E, Horn D, Filip R, Freier K, Ganse B, Classen C
Clin Biomech (Bristol)
. 2024 May;
115:106259.
PMID: 38714110
Background: The ability to walk safely after head and neck reconstruction with fibular free flaps in tumor surgery is a high priority for patients. In addition, surgeons and patients require...
6.
Moratin J, Maas T, Horn D, Semmelmayer K, Zittel S, Oehme M, et al.
Clin Oral Investig
. 2024 Apr;
28(5):268.
PMID: 38652328
No abstract available.
7.
Moratin J, Maas T, Horn D, Semmelmayer K, Zittel S, Oehme M, et al.
Clin Oral Investig
. 2024 Mar;
28(4):229.
PMID: 38530421
Objectives: In the presented study, the occurrence rates of second primary oral carcinomas and their prognostic relevance were analyzed. Materials And Methods: All patients with surgically treated oral squamous cell...
8.
Radermacher A, Fehrenz M, Bellin T, Classen C, Moller L, Struckmeier A, et al.
Int J Mol Sci
. 2023 Dec;
24(23).
PMID: 38069020
The human leukocyte antigene E (HLA-E) is associated with tumorigenesis in various cancers. Immunoncology along with sex-specific aspects in cancer therapy are now in scientific focus. Therefore, immunohistochemical HLA-E expression...
9.
Steen S, Semmelmayer K, Flechtenmacher C, Hoffmann J, Freier K, Horn D, et al.
Int J Mol Sci
. 2023 Nov;
24(22).
PMID: 38003576
The introduction of immune checkpoint inhibition for recurrent and metastatic head and neck cancer has brought a new treatment option for patients suffering from advanced oral cancers without a chance...
10.
Zittel S, Moratin J, Awounvo S, Ruckschloss T, Freier K, Ristow O, et al.
J Clin Med
. 2023 Oct;
12(20).
PMID: 37892740
Background: Patients with recurrent oral squamous cell carcinoma (OSCC) have limited treatment options. Salvage surgery offers potential curative therapy. The need for extensive ablative surgery together with microvascular reconstruction implies...